Dr Diane Louise Leyba, MD - Medicare Obstetrics & Gynecology in Newport, OR

Dr Diane Louise Leyba, MD is a medicare enrolled "Obstetrics & Gynecology" physician in Newport, Oregon. Her current practice location is 930 Sw Abbey St Ste B, Newport, Oregon. You can reach out to her office (for appointments etc.) via phone at (541) 574-7235.

Dr Diane Louise Leyba is licensed to practice in Arizona (license number 63118) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1275544728.

Contact Information

Dr Diane Louise Leyba, MD
930 Sw Abbey St Ste B,
Newport, OR 97365-4820
(541) 574-7235
Not Available



Physician's Profile

Full NameDr Diane Louise Leyba
GenderFemale
SpecialityObstetrics & Gynecology
Location930 Sw Abbey St Ste B, Newport, Oregon
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1275544728
  • Provider Enumeration Date: 08/10/2006
  • Last Update Date: 08/22/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 7517011026
  • Enrollment ID: I20090818000862

Medical Identifiers

Medical identifiers for Dr Diane Louise Leyba such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1275544728NPI-NPPES
500609240MedicaidOR
092689MedicaidAZ
63118OtherAZAZ STATE MEDICAL LICENSING

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207V00000XObstetrics & Gynecology MD29227 (Oregon)Secondary
207V00000XObstetrics & Gynecology 63118 (Arizona)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Diane Louise Leyba allows following entities to bill medicare on her behalf.
Entity NameMid-valley Healthcare Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1689625980
PECOS PAC ID: 2769391523
Enrollment ID: O20031111000297

News Archive

Discovery of biological markers that may indicate poor breast cancer prognosis

A team of researchers has found an association between breast cancer survival and two proteins that, when present in the blood in high levels, are indicators of inflammation.

Innovate UK awards major grant to develop Rheumatoid Arthritis Flare Profiler

A partnership between the healthtech company Living With, the Royal United Hospitals Bath NHS Foundation Trust, and the University of Bath has been awarded a major grant to develop a Rheumatoid Arthritis Flare Profiler.

Orphan, CU to develop enzyme replacement therapy for CBS-deficient homocystinuria

The University of Colorado (CU) has signed exclusive, worldwide licensing and collaboration agreements with rare-disease research-and-development firm Orphan Technologies Ltd to develop an enzyme replacement therapy for Cystathionine Beta-Synthase (CBS) -deficient homocystinuria, a rare, inherited metabolic disease that is often fatal at a young age.

New York smoking ban gone too far? Health experts disagree

Now there is a faction that believes the soon-to-pass smoking ban on most parks and many beaches throughout New York City to be "going too far" and is questioning the bill.

Read more Medical News

› Verified 7 days ago

Entity NameGood Samaritan Hospital Corvallis
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1962453134
PECOS PAC ID: 1557270725
Enrollment ID: O20031125000163

News Archive

Discovery of biological markers that may indicate poor breast cancer prognosis

A team of researchers has found an association between breast cancer survival and two proteins that, when present in the blood in high levels, are indicators of inflammation.

Innovate UK awards major grant to develop Rheumatoid Arthritis Flare Profiler

A partnership between the healthtech company Living With, the Royal United Hospitals Bath NHS Foundation Trust, and the University of Bath has been awarded a major grant to develop a Rheumatoid Arthritis Flare Profiler.

Orphan, CU to develop enzyme replacement therapy for CBS-deficient homocystinuria

The University of Colorado (CU) has signed exclusive, worldwide licensing and collaboration agreements with rare-disease research-and-development firm Orphan Technologies Ltd to develop an enzyme replacement therapy for Cystathionine Beta-Synthase (CBS) -deficient homocystinuria, a rare, inherited metabolic disease that is often fatal at a young age.

New York smoking ban gone too far? Health experts disagree

Now there is a faction that believes the soon-to-pass smoking ban on most parks and many beaches throughout New York City to be "going too far" and is questioning the bill.

Read more Medical News

› Verified 7 days ago

Entity NameSamaritan North Lincoln Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1306897491
PECOS PAC ID: 7911816301
Enrollment ID: O20040120000329

News Archive

Discovery of biological markers that may indicate poor breast cancer prognosis

A team of researchers has found an association between breast cancer survival and two proteins that, when present in the blood in high levels, are indicators of inflammation.

Innovate UK awards major grant to develop Rheumatoid Arthritis Flare Profiler

A partnership between the healthtech company Living With, the Royal United Hospitals Bath NHS Foundation Trust, and the University of Bath has been awarded a major grant to develop a Rheumatoid Arthritis Flare Profiler.

Orphan, CU to develop enzyme replacement therapy for CBS-deficient homocystinuria

The University of Colorado (CU) has signed exclusive, worldwide licensing and collaboration agreements with rare-disease research-and-development firm Orphan Technologies Ltd to develop an enzyme replacement therapy for Cystathionine Beta-Synthase (CBS) -deficient homocystinuria, a rare, inherited metabolic disease that is often fatal at a young age.

New York smoking ban gone too far? Health experts disagree

Now there is a faction that believes the soon-to-pass smoking ban on most parks and many beaches throughout New York City to be "going too far" and is questioning the bill.

Read more Medical News

› Verified 7 days ago

Entity NameSamaritan Pacific Health Services Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1174888010
PECOS PAC ID: 2466353529
Enrollment ID: O20040204000304

News Archive

Discovery of biological markers that may indicate poor breast cancer prognosis

A team of researchers has found an association between breast cancer survival and two proteins that, when present in the blood in high levels, are indicators of inflammation.

Innovate UK awards major grant to develop Rheumatoid Arthritis Flare Profiler

A partnership between the healthtech company Living With, the Royal United Hospitals Bath NHS Foundation Trust, and the University of Bath has been awarded a major grant to develop a Rheumatoid Arthritis Flare Profiler.

Orphan, CU to develop enzyme replacement therapy for CBS-deficient homocystinuria

The University of Colorado (CU) has signed exclusive, worldwide licensing and collaboration agreements with rare-disease research-and-development firm Orphan Technologies Ltd to develop an enzyme replacement therapy for Cystathionine Beta-Synthase (CBS) -deficient homocystinuria, a rare, inherited metabolic disease that is often fatal at a young age.

New York smoking ban gone too far? Health experts disagree

Now there is a faction that believes the soon-to-pass smoking ban on most parks and many beaches throughout New York City to be "going too far" and is questioning the bill.

Read more Medical News

› Verified 7 days ago

Entity NameAlbany General Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1154372340
PECOS PAC ID: 9931097987
Enrollment ID: O20040310000310

News Archive

Discovery of biological markers that may indicate poor breast cancer prognosis

A team of researchers has found an association between breast cancer survival and two proteins that, when present in the blood in high levels, are indicators of inflammation.

Innovate UK awards major grant to develop Rheumatoid Arthritis Flare Profiler

A partnership between the healthtech company Living With, the Royal United Hospitals Bath NHS Foundation Trust, and the University of Bath has been awarded a major grant to develop a Rheumatoid Arthritis Flare Profiler.

Orphan, CU to develop enzyme replacement therapy for CBS-deficient homocystinuria

The University of Colorado (CU) has signed exclusive, worldwide licensing and collaboration agreements with rare-disease research-and-development firm Orphan Technologies Ltd to develop an enzyme replacement therapy for Cystathionine Beta-Synthase (CBS) -deficient homocystinuria, a rare, inherited metabolic disease that is often fatal at a young age.

New York smoking ban gone too far? Health experts disagree

Now there is a faction that believes the soon-to-pass smoking ban on most parks and many beaches throughout New York City to be "going too far" and is questioning the bill.

Read more Medical News

› Verified 7 days ago

Entity NameSamaritan North Lincoln Hospital
Entity TypePart A Provider - Critical Access Hospital
Entity IdentifiersNPI Number: 1306897491
PECOS PAC ID: 7911816301
Enrollment ID: O20061104000117

News Archive

Discovery of biological markers that may indicate poor breast cancer prognosis

A team of researchers has found an association between breast cancer survival and two proteins that, when present in the blood in high levels, are indicators of inflammation.

Innovate UK awards major grant to develop Rheumatoid Arthritis Flare Profiler

A partnership between the healthtech company Living With, the Royal United Hospitals Bath NHS Foundation Trust, and the University of Bath has been awarded a major grant to develop a Rheumatoid Arthritis Flare Profiler.

Orphan, CU to develop enzyme replacement therapy for CBS-deficient homocystinuria

The University of Colorado (CU) has signed exclusive, worldwide licensing and collaboration agreements with rare-disease research-and-development firm Orphan Technologies Ltd to develop an enzyme replacement therapy for Cystathionine Beta-Synthase (CBS) -deficient homocystinuria, a rare, inherited metabolic disease that is often fatal at a young age.

New York smoking ban gone too far? Health experts disagree

Now there is a faction that believes the soon-to-pass smoking ban on most parks and many beaches throughout New York City to be "going too far" and is questioning the bill.

Read more Medical News

› Verified 7 days ago

Entity NameMid-valley Healthcare Inc
Entity TypePart A Provider - Critical Access Hospital
Entity IdentifiersNPI Number: 1689625980
PECOS PAC ID: 2769391523
Enrollment ID: O20061104000140

News Archive

Discovery of biological markers that may indicate poor breast cancer prognosis

A team of researchers has found an association between breast cancer survival and two proteins that, when present in the blood in high levels, are indicators of inflammation.

Innovate UK awards major grant to develop Rheumatoid Arthritis Flare Profiler

A partnership between the healthtech company Living With, the Royal United Hospitals Bath NHS Foundation Trust, and the University of Bath has been awarded a major grant to develop a Rheumatoid Arthritis Flare Profiler.

Orphan, CU to develop enzyme replacement therapy for CBS-deficient homocystinuria

The University of Colorado (CU) has signed exclusive, worldwide licensing and collaboration agreements with rare-disease research-and-development firm Orphan Technologies Ltd to develop an enzyme replacement therapy for Cystathionine Beta-Synthase (CBS) -deficient homocystinuria, a rare, inherited metabolic disease that is often fatal at a young age.

New York smoking ban gone too far? Health experts disagree

Now there is a faction that believes the soon-to-pass smoking ban on most parks and many beaches throughout New York City to be "going too far" and is questioning the bill.

Read more Medical News

› Verified 7 days ago

Entity NameSamaritan Pacific Health Services Inc
Entity TypePart A Provider - Critical Access Hospital
Entity IdentifiersNPI Number: 1801847066
PECOS PAC ID: 2466353529
Enrollment ID: O20061104000163

News Archive

Discovery of biological markers that may indicate poor breast cancer prognosis

A team of researchers has found an association between breast cancer survival and two proteins that, when present in the blood in high levels, are indicators of inflammation.

Innovate UK awards major grant to develop Rheumatoid Arthritis Flare Profiler

A partnership between the healthtech company Living With, the Royal United Hospitals Bath NHS Foundation Trust, and the University of Bath has been awarded a major grant to develop a Rheumatoid Arthritis Flare Profiler.

Orphan, CU to develop enzyme replacement therapy for CBS-deficient homocystinuria

The University of Colorado (CU) has signed exclusive, worldwide licensing and collaboration agreements with rare-disease research-and-development firm Orphan Technologies Ltd to develop an enzyme replacement therapy for Cystathionine Beta-Synthase (CBS) -deficient homocystinuria, a rare, inherited metabolic disease that is often fatal at a young age.

New York smoking ban gone too far? Health experts disagree

Now there is a faction that believes the soon-to-pass smoking ban on most parks and many beaches throughout New York City to be "going too far" and is questioning the bill.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Diane Louise Leyba is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Diane Louise Leyba, MD
Po Box 2847,
Corvallis, OR 97339-2847

Ph: () -
Dr Diane Louise Leyba, MD
930 Sw Abbey St Ste B,
Newport, OR 97365-4820

Ph: (541) 574-7235

News Archive

Discovery of biological markers that may indicate poor breast cancer prognosis

A team of researchers has found an association between breast cancer survival and two proteins that, when present in the blood in high levels, are indicators of inflammation.

Innovate UK awards major grant to develop Rheumatoid Arthritis Flare Profiler

A partnership between the healthtech company Living With, the Royal United Hospitals Bath NHS Foundation Trust, and the University of Bath has been awarded a major grant to develop a Rheumatoid Arthritis Flare Profiler.

Orphan, CU to develop enzyme replacement therapy for CBS-deficient homocystinuria

The University of Colorado (CU) has signed exclusive, worldwide licensing and collaboration agreements with rare-disease research-and-development firm Orphan Technologies Ltd to develop an enzyme replacement therapy for Cystathionine Beta-Synthase (CBS) -deficient homocystinuria, a rare, inherited metabolic disease that is often fatal at a young age.

New York smoking ban gone too far? Health experts disagree

Now there is a faction that believes the soon-to-pass smoking ban on most parks and many beaches throughout New York City to be "going too far" and is questioning the bill.

Read more News

› Verified 7 days ago


Obstetrics & Gynecology Doctors in Newport, OR

Dr. Michael Paul Adler, MD
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 930 Sw Abbey St Ste B, Newport, OR 97365
Phone: 541-574-7235    
Dr. James Gerard Zolzer, MD
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 930 Sw Abbey St Ste B, Newport, OR 97365
Phone: 541-574-7235    
Mr. Daniel Duane Kort, M.D.
Obstetrics & Gynecology
Medicare: Not Enrolled in Medicare
Practice Location: 130 Nw 19th St., Suite A, Newport, OR 97364
Phone: 541-264-8332    Fax: 541-264-8376
Karen Fleenor Bunn, M.D.
Obstetrics & Gynecology
Medicare: Medicare Enrolled
Practice Location: 930 Sw Abbey St Ste B, Newport, OR 97365
Phone: 541-574-7235    
Dr. Ian Ross Donald, MD
Obstetrics & Gynecology
Medicare: Medicare Enrolled
Practice Location: 775 Sw 9th St Ste H, Newport, OR 97365
Phone: 541-574-4767    Fax: 541-574-4747
Michael Swift, DO
Obstetrics & Gynecology
Medicare: Medicare Enrolled
Practice Location: 930 Sw Abbey St Ste B, Newport, OR 97365
Phone: 541-574-7235    Fax: 541-812-2077

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.